Eam Investors, LLC Biolife Solutions Inc Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$32.95 - $44.24 $1.57 Million - $2.11 Million	-47,636 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$27.5 - $45.75 $166,045 - $276,238	-6,038 Reduced 11.25%	47,636 $1.9 Million
Q3 2020 Nov 13, 2020	BUY	$16.04 - $28.94 $860,930 - $1.55 Million	53,674 New	53,674 $1.55 Million
Q4 2018 Feb 13, 2019	SELL	$9.5 - $17.17 $746,082 - $1.35 Million	-78,535 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$14.99 - $25.48 $1.56 Million - $2.66 Million	-104,376 Reduced 57.06%	78,535 $1.37 Million

Q2 2018 Aug 03, 2018	BUY	$6.18 - $13.49 $544,952 - $1.19 Million	88,180 Added 93.08%	182,911 $2.09 Million
Q1 2018 May 14, 2018	SELL	$4.73 - $6.03 $11,096 - $14,146	-2,346 Reduced 2.42%	94,731 $484,000
Q3 2017 Nov 08, 2017	BUY	$3.45 - $5.71 $334,915 - $554,309	97,077	97,077 $555,000

206

47.6M

12.6K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.03B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.